WAP
VCYT icon

Wealthcare Advisory Partners’s Veracyte VCYT Stock Holding History

Wealthcare Advisory Partners’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-850
Closed -$46K – 1806
2021
Q1 		$46K Buy
+850
New +$49K ﹤0.01% 905

Other funds holding VCYT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wealthcare Advisory Partners's VCYT Position: Q2 2021 in Review

Wealthcare Advisory Partners sold out of Veracyte (VCYT) in Q2 2021, closing a stake of 850 shares — an estimated $46K sold.

Wealthcare Advisory Partners first reported a position in VCYT in Q1 2021 and held it in 1 quarter. The position peaked at $46K in Q1 2021. 214 funds tracked by Wall St. Rank hold VCYT as of Q2 2021.

  • Wealthcare Advisory Partners reported no remaining Veracyte position as of Q2 2021 after selling out during the quarter.
  • Wealthcare Advisory Partners sold 850 Veracyte shares in Q2 2021, an estimated $46K.
  • Wealthcare Advisory Partners first reported a position in Veracyte in Q1 2021 and held it in 1 quarter.
  • Wealthcare Advisory Partners's Veracyte position peaked at $46K in Q1 2021.
  • 214 funds tracked by Wall St. Rank held Veracyte as of Q2 2021.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2021, filed 16 Aug 2021.